Kalinox (Nitrous Oxide, Oxygen)

Kalinox, a nitrous oxide/oxygen mixture, is used within the analgesic and anesthetic pathway for procedural sedation.

• Minor surgical procedures: delivers rapid analgesia and anxiolysis during brief operations.
• Diagnostic procedures: reduces pain and discomfort during endoscopy, dental work and other minor investigations.
• Adjunct to general anesthesia: supplies supplemental oxygen and maintains analgesic effect during induction and maintenance of anesthesia.

• Nitrous oxide acts as an NMDA receptor antagonist, producing analgesic and anxiolytic effects, while also stimulating endogenous opioid pathways. The accompanying oxygen component ensures adequate ventilation and oxygenation during inhalation, supporting respiratory function throughout the procedure.

Common side effects are generally mild and transient.

Common Side Effects

• Nausea: mild to moderate feeling of sickness.
• Vomiting: occasional emesis during or after administration.
• Dizziness: transient light‑headedness.
• Headache: mild headache after exposure.
• Dry mouth: reduced salivation.
• Euphoria: brief feeling of well‑being.

Serious or Rare Side Effects

• Hypoxia: reduced blood oxygen levels if oxygen supply is inadequate.
• Respiratory depression: slowed breathing requiring monitoring.
• Loss of consciousness: rare but possible with excessive dosing.
• Severe hypotension: marked drop in blood pressure.
• Allergic reaction: rash, itching or swelling.
• Pulmonary edema: fluid accumulation in lungs in extreme cases.

When using Kalinox, careful assessment and monitoring are essential to ensure patient safety.

• Patient assessment: evaluate respiratory status and contraindications before administration.
• Contraindications: avoid in patients with severe COPD, pneumothorax, or known vitamin B12 deficiency.
• Equipment check: ensure proper scavenging and delivery system integrity.
• Monitoring: continuously observe oxygen saturation, heart rate and level of consciousness.
• Pregnancy and lactation: use only if benefit outweighs potential risk, as safety data are limited.
• Storage: Store at ambient temperature: keep cylinder upright, protect from heat and direct sunlight.

Kalinox may interact with other agents that affect the central nervous system or respiratory function.

Major Interactions (Avoid)

• Other inhalational anesthetics: may potentiate respiratory depression.
• Sedatives or hypnotics: increase risk of excessive sedation.
• Alcohol: additive depressant effect on CNS.
• Opioids: may enhance respiratory depression.
• Nitrites: can cause severe hypotension.

Moderate Interactions (Monitor Closely)

• Benzodiazepines: may require dose adjustment.
• MAO inhibitors: monitor for heightened cardiovascular effects.
• Antidepressants (SSRIs/SNRIs): watch for serotonin syndrome signs.
• Antihypertensives: potential additive blood pressure lowering.
• Anticholinergics: may exacerbate dry mouth.